百川大模型發佈醫療大模型Baichuan-M2Plus，升級應用百小應並開放API接口。評測顯示，該模型醫療幻覺率顯著低於通用大模型，較DeepSeek降低約3倍，表現優於美國OpenEvidence應用。
百川科技發佈醫療大模型Baichuan-M2Plus，號稱“醫生版ChatGPT”，旨在提升醫療智能輔助能力。其採用六源循證推理範式，顯著提高知識準確性和可靠性，大幅降低醫療“幻覺”率，性能優於美國產品OpenEvidence。這是百川在醫療AI領域的重要進展。
百川大模型發佈醫療大模型Baichuan-M2Plus，升級百小應應用並開放API。該模型在醫療幻覺率上表現突出，較通用模型大幅降低，相比現有醫療產品DeepSeek降低約3倍，並超越美國OpenEvidence。基於創新的六源循證技術，提升了醫療問答的準確性。
醫療AI公司OpenEvidence近日完成2億美元融資，估值達60億美元。這是繼三個月前融資2.1億美元后再次獲得大額投資，顯示投資者對醫療AI領域興趣濃厚。該公司成立於2022年，專注於爲醫護人員提供快速獲取醫療知識的解決方案。
%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20fill:%20%23061b40;%20}%20.st1%20{%20fill:%20%23306af1;%20}%20.st2%20{%20fill:%20%235ce5cf;%20}%20%3c/style%3e%3c/defs%3e%3cg%3e%3cpath%20class='st0'%20d='M55,10.5h9v3h-9v9h12V7.5h-12v3ZM64,19.5h-6v-3h6v3Z'/%3e%3cpolygon%20class='st0'%20points='69%2016.5%2078%2016.5%2078%2019.5%2069%2019.5%2069%2022.5%2081%2022.5%2081%2013.5%2072%2013.5%2072%2010.5%2081%2010.5%2081%207.5%2069%207.5%2069%2016.5'/%3e%3cpolygon%20class='st0'%20points='95%2010.5%2095%207.5%2083%207.5%2083%2022.5%2095%2022.5%2095%2019.5%2086%2019.5%2086%2016.5%2095%2016.5%2095%2013.5%2086%2013.5%2086%2010.5%2095%2010.5'/%3e%3cpath%20class='st0'%20d='M40,1.5v21h11.6l1.4-1.4v-7.6h0c0,0-1.4-1.5-1.4-1.5l1.4-1.4V2.9l-1.4-1.4h-11.6ZM50,19.5h-7v-6h7v6ZM50,10.5h-7v-6h7v6Z'/%3e%3c/g%3e%3cpath%20class='st1'%20d='M23.1,24L14.7,4.8l-4.9,11.2h3.8l-1.8,4H3.3L12.1,0H2C.9,0,0,.9,0,2v20c0,1.1.9,2,2,2h21.1Z'/%3e%3cpath%20class='st2'%20d='M34,0h-16.8l10.6,24h6.2c1.1,0,2-.9,2-2V2C36,.9,35.1,0,34,0ZM32.5,20h-4V4h4v16Z'/%3e%3c/svg%3e)
